Locally delivered bisphosphonate for enhancement of bone formation and implant fixation.
Bobyn
J Dennis
JD
Montreal General Hospital, Montreal, QC, Canada. john.bobyn@mcgill.ca
McKenzie
Kimberly
K
Karabasz
Dorota
D
Krygier
Jan J
JJ
Tanzer
Michael
M
D000818:Animals; D001672:Biocompatible Materials; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D007093:Imidazoles / Q000008:administration & dosage*; D023421:Models, Animal; D016348:Osseointegration / Q000187:drug effects*; D010012:Osteogenesis / Q000187:drug effects*; D013635:Tantalum; D000077211:Zoledronic Acid
D001672:Biocompatible Materials; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D013635:Tantalum; D000077211:Zoledronic Acid